{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:44:12Z","timestamp":1761561852532},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,3,23]],"date-time":"2014-03-23T00:00:00Z","timestamp":1395532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s11239-014-1052-y","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T15:19:23Z","timestamp":1395501563000},"page":"355-363","source":"Crossref","is-referenced-by-count":5,"title":["Sirolimus-eluting versus paclitaxel-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials"],"prefix":"10.1007","volume":"38","author":[{"given":"Giuseppe","family":"De Luca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Wirianta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Di Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Suryapranata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,23]]},"reference":[{"key":"1052_CR1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ajem.2008.04.026","volume":"27","author":"G Luca De","year":"2009","unstructured":"De Luca G, Cassetti E, Marino P (2009) Percutaneous coronary intervention-related time delay, patient\u2019s risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction. Am J Emerg Med 27:712\u2013719","journal-title":"Am J Emerg Med"},{"key":"1052_CR2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.annemergmed.2008.08.033","volume":"52","author":"G Luca De","year":"2008","unstructured":"De Luca G, Biondi-Zoccai G, Marino P (2008) Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials. Ann Emerg Med 52:665\u2013676","journal-title":"Ann Emerg Med"},{"key":"1052_CR3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjcard.2010.08.063","volume":"107","author":"G Luca De","year":"2011","unstructured":"De Luca G, Navarese EP, Cassetti E, Verdoia M, Suryapranata H (2011) Metaanalysis of randomized trials of glycoprotein IIb\/IIIa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy. Am J Cardiol 107:198\u2013203","journal-title":"Am J Cardiol"},{"key":"1052_CR4","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/jama.293.14.1759","volume":"293","author":"G Luca De","year":"2005","unstructured":"De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann FJ et al (2005) Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 293:1759\u20131765","journal-title":"JAMA"},{"key":"1052_CR5","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/j.1538-7836.2011.04513.x","volume":"9","author":"G Luca De","year":"2011","unstructured":"De Luca G, Bellandi F, Huber K (2011) Noc M, Petronio AS, Arntz HR, Maioli M, Gabriel HM, Zorman S, DE Carlo M, Rakowski T, Gyongyosi M, Dudek D. Early glycoprotein IIb\u2013IIIa inhibitors in primary angioplasty\u2013abciximab long-term results (EGYPT-ALT) cooperation: individual patient\u2019s data meta-analysis. J Thromb Haemost 9:2361\u20132370","journal-title":"J Thromb Haemost"},{"key":"1052_CR6","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(11)60764-2","volume":"377","author":"GW Stone","year":"2011","unstructured":"Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, On behalf of the HORIZONS-AMI trial investigators et al (2011) Heparin plus a glycoprotein IIb\/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet 377:2193\u20132204","journal-title":"Lancet"},{"key":"1052_CR7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1160\/TH09-05-0287","volume":"102","author":"G Luca De","year":"2009","unstructured":"De Luca G, Cassetti E, Verdoia M, Marino P (2009) Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty: a meta-analysis of randomised trials. Thromb Haemost 102:428\u2013436","journal-title":"Thromb Haemost"},{"key":"1052_CR8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMoa013404","volume":"346","author":"GW Stone","year":"2002","unstructured":"Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ et al (2002) Controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346:957\u2013966","journal-title":"N Engl J Med"},{"key":"1052_CR9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/hrt.2004.056705","volume":"91","author":"H Suryapranata","year":"2005","unstructured":"Suryapranata H, De Luca G, van\u2019t Hof AW, Ottervanger JP, Hoorntje JC, Dambrink JH et al (2005) Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomized comparison in a large unselected cohort of patients. Heart 91:641\u2013645","journal-title":"Heart"},{"key":"1052_CR10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijcard.2007.03.112","volume":"126","author":"G Luca De","year":"2008","unstructured":"De Luca G, Suryapranata H, Stone GW, Antoniucci D, Biondi-Zoccai G, Kastrati A et al (2008) Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials. Int J Cardiol 126:37\u201344","journal-title":"Int J Cardiol"},{"key":"1052_CR11","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","volume":"349","author":"JW Moses","year":"2003","unstructured":"Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O\u2019Shaughnessy C, SIRIUS Investigators et al (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315\u20131323","journal-title":"N Engl J Med"},{"key":"1052_CR12","doi-asserted-by":"crossref","unstructured":"De Luca G, Valgimigli M, Spaulding C, Menichelli M, Brunner-La Rocca HP, van der Hoeven BL, Di Lorenzo E, Diaz de la Llera LS, Pasceri V, Pittl U, Percoco G, Violini R, Stone GW (2009) Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. J Thromb Thrombolysis 28:200\u2013210","DOI":"10.1007\/s11239-009-0305-7"},{"key":"1052_CR13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijcard.2007.12.040","volume":"133","author":"G Luca De","year":"2009","unstructured":"De Luca G, Stone GW, Suryapranata H, Laarman GJ, Menichelli M, Kaiser C et al (2009) Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. Int J Cardiol 133:213\u2013222","journal-title":"Int J Cardiol"},{"key":"1052_CR14","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jacc.2007.06.047","volume":"50","author":"A Schomig","year":"2007","unstructured":"Schomig A, Dibra A, Windecker S et al (2007) A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitax eleluting stents in patients with coronary artery disease. J Am Coll Cardiol 50:1373\u20131380","journal-title":"J Am Coll Cardiol"},{"key":"1052_CR15","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, Academic Research Consortium (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344\u20132351","journal-title":"Circulation"},{"key":"1052_CR16","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","volume":"354","author":"D Moher","year":"1999","unstructured":"Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354:1896\u20131900","journal-title":"Lancet"},{"key":"1052_CR17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ccd.21510","volume":"72","author":"JH Lee","year":"2008","unstructured":"Lee JH, Kim HS, Lee SW et al (2008) Prospective randomized comparison of sirolimus-versus paclitaxel-eluting stents for the treatment of acute ST elevation myocardial infarction: pROSIT trial. Catheter Cardiovasc Interv 72:25\u201332","journal-title":"Catheter Cardiovasc Interv"},{"key":"1052_CR18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijcard.2009.09.466","volume":"147","author":"HS Kim","year":"2011","unstructured":"Kim HS, Lee JH, Lee SW, Kim YH, Park JH, Choi SW, Jeong JO, Seong IW, Rhee KS, Ko JK, Jo SH (2011) Choi YJ.Long-term safety and efficacy of sirolimus- vs. paclitaxel-eluting stent implantation for acute ST-elevation myocardial infarction: 3-year follow-up of the PROSIT trial. Int J Cardiol 147:253\u2013257","journal-title":"Int J Cardiol"},{"key":"1052_CR19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.amjcard.2009.03.015","volume":"104","author":"YB Juwana","year":"2009","unstructured":"Juwana YB, Suryapranata H, Ottervanger JP et al (2009) Comparison of rapamycin- and paclitaxel-eluting stents in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol 104:205\u2013209","journal-title":"Am J Cardiol"},{"key":"1052_CR20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jcin.2009.03.012","volume":"2","author":"E Lorenzo Di","year":"2009","unstructured":"Di Lorenzo E, De Luca G, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, Rosato G (2009) The PASEO (PaclitAxel or Sirolimus-Eluting stent versus bare metal stent in primary angioplasty) randomized trial. JACC Cardiovasc Interv 2:515\u2013523","journal-title":"JACC Cardiovasc Interv"},{"key":"1052_CR21","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.ahj.2009.03.016","volume":"158","author":"E Di Lorenzo","year":"2009","unstructured":"Di Lorenzo E, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F et al (2009) Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial. Am Heart J 158:e43\u2013e50","journal-title":"Am Heart J"},{"issue":"Abstract Suppl","key":"1052_CR22","first-page":"650","volume":"27","author":"U Pittl","year":"2006","unstructured":"Pittl U, Kaiser C, Brunner-La Rocca HP, BASKET Investigators (2006) Safety and efficacy of drug eluting stents versus bare metal stents in primary angioplasty of patients with acute ST-elevation myocardial infarction\u2014a prospective randomized study. Eur Heart J 27(Abstract Suppl):650","journal-title":"Eur Heart J"},{"key":"1052_CR23","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.amjcard.2009.06.059","volume":"104","author":"CW Lee","year":"2009","unstructured":"Lee CW, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Yun SC, Seong IW, Lee JH, Lee NH, Cho YH, Cheong SS, Lim DS, Yang JY, Lee SG, Kim KS, Yoon J, Jeong MH, Seung KB, Hong TJ, Park SJ, ZEST-AMI Investigators (2009) Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction. Am J Cardiol. 104:1370\u20131376","journal-title":"Am J Cardiol."},{"key":"1052_CR24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/archinternmed.2012.758","volume":"172","author":"G Luca De","year":"2012","unstructured":"De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, de D\u00edaz la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Cortese G, Suryapranata H, Stone GW (2012) Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. Arch Intern Med 172:611\u2013621","journal-title":"Arch Intern Med"},{"key":"1052_CR25","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","volume":"379","author":"T Palmerini","year":"2012","unstructured":"Palmerini T, Biondi-Zoccai G, Della Riva D, Stettler C, Sangiorgi D, D\u2019Ascenzo F, Kimura T, Briguori C, Sabat\u00e8 M, Kim HS, De Waha A, Kedhi E, Smits PC, Kaiser C, Sardella G, Marullo A, Kirtane AJ, Leon MB, Stone GW (2012) Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 379:1393\u20131402","journal-title":"Lancet"},{"key":"1052_CR26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jacc.2012.01.073","volume":"60","author":"SH Hofma","year":"2012","unstructured":"Hofma SH, Brouwer J, Velders MA, van\u2019t Hof AW, Smits PC, Quer\u00e9 M, de Vries CJ, van Boven AJ (2012) Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial. J Am Coll Cardiol 60:381\u2013387","journal-title":"J Am Coll Cardiol"},{"key":"1052_CR27","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0140-6736(12)61223-9","volume":"380","author":"M Sabate","year":"2012","unstructured":"Sabate M, Cequier A, I\u00f1iguez A, Serra A, Hernandez-Antolin R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vazquez N, G\u00f3mez-Hospital JA, Baz JA, Martin-Yuste V, van Geuns RJ, Alfonso F, Bordes P, Tebaldi M, Masotti M, Silvestro A, Backx B, Brugaletta S, van Es GA, Serruys PW (2012) Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1\u00a0year results of a randomised controlled trial. Lancet 380:1482\u20131490","journal-title":"Lancet"},{"key":"1052_CR28","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4244\/EIJV7I8A155","volume":"7","author":"EP Navarese","year":"2011","unstructured":"Navarese EP, Kubica J, Castriota F, Gibson CM, De Luca G, Buffon A, Bolognese L, Margheri M, Andreotti F, Di Mario C, De Servi S (2011) Safety and efficacy of biodegradable vs durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials. EuroIntervention 7:985\u2013994","journal-title":"EuroIntervention"},{"key":"1052_CR29","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045\u20131057","journal-title":"N Engl J Med"},{"key":"1052_CR30","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, TRITON-TIMI 38 Investigators et al (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001\u20132015","journal-title":"N Engl J Med"},{"key":"1052_CR31","author":"M Verdoia","year":"2013","unstructured":"Verdoia M, Schaffer A, Barbieri L, Cassetti E, Piccolo R, Galasso G, Marino P, Sinigaglia F, De Luca G (2013) Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials. J Cardiovasc Pharmacol. doi: 10.1097\/FJC.0000000000000052","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-014-1052-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-014-1052-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-014-1052-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T08:16:07Z","timestamp":1716624967000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-014-1052-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,23]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["1052"],"URL":"https:\/\/doi.org\/10.1007\/s11239-014-1052-y","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,23]]}}}